I've Been Diagnosed With Prostate Cancer - What Now? | Dr Steven Tucker

Smart Insurance Choices
22 followers
18 Video Views·Dec 17, 2025
“I’ve been diagnosed with prostate cancer, what should I do now?”
Whether you (or a loved one) have recently received a prostate cancer diagnosis, this video will explain what some next steps may be, and the treatment options you may have depending on your condition - or if you even need treatment at all.
Take a deep breath, and watch our video to learn from Dr Steven Tucker, Medical Oncologist and Founder of Tucker Medical.
For more information and enquiries for appointments, email our nurses at: [email protected]
-
Subscribe to our Youtube channel for more oncology-related topics, personalized medicine, holistic care, and more!
Visit www.tuckermedical.com to check out our team and the services we provide!
So you were just diagnosed with prostate cancer. What now? I'm Dr. Steve Tucker, Medical Oncologist.
Let's talk about treatment for newly diagnosed prostate cancer. And we're going to talk today
about early prostate cancer, which means not prostate cancer that's spread to the bone,
but prostate cancer where someone's going to speak with you about the treatment options,
which includes surgery in all sorts of forms, radiation, many different techniques,
hormone therapy, which is often combined with radiation, or what we call active surveillance
with delayed or deferred intervention, which we used to call watchful waiting.
Really, it's observation. It's an option that says, we might treat you. We just don't think
we need to treat you this year. And that's a good choice for a lot of men as well.
Now, what do we really need to do? You understand all those options, and it gets very confusing what
to do. But I'm going to point out the very first step that should be taken after a prostate biopsy
and a diagnosis of prostate cancer is a second opinion on the pathology. Patients often go
through a lot of process to choose their surgeons for the biopsy, but nobody goes out and picks
their own pathologist. The pathologist is critical because they are the only person in the chain
that said you have prostate cancer. People often say, I say to the patients, who told you you had
prostate cancer? The surgeon. Well, who told the surgeon? The pathologist. The pathologist is key.
Everyone should get a second opinion on their prostate cancer pathology because there is a
subjective element to this. And without getting too technical, you can see from the images behind
me, we use something called a Gleason score created by Dr. Gleason. And in simple form,
we look under the microscope twice and assign a score of one to five. And then we look again for
secondary features and assign another score of one to five. So the lowest score is a two and the
highest is a 10. 8, 9, 10s are considered high risk, less than six, six or less is lower risk
and sevens are intermediate. This is going to be important because that second opinion is really
critical to helping put newly diagnosed patients into these risk groups. Now, these risk groups
are not risk of life or death. Prostate cancer treatment or observation five years from diagnosis,
a hundred percent survival. Did you hear that? A hundred percent survival. Stage one, two,
three prostate cancers, whether you do everything or nothing, a hundred percent survival. Now,
that said, prostate cancer treatments are strongly associated with side effects,
including permanent side effects. Surgery and radiation will have problems with rectal
bleeding, erectile function, sexuality, urinary control. You might need to buy diapers. So
there are permanent enduring problems with a lot of the prostate cancer treatments. Not that you
shouldn't pursue those treatments, but you need to be aware that that's something that happens
in trying to get cured. So what I ask patients to do is to take a step back and we put them
into a risk group. And those risk groups, as I said, are low intermediate and high risk,
not risk of death, but risk that the PSA blood test will go from zero back to some measurable
number years later. So let's think about this. The whole process started because the PSA blood
test was elevated. And then after surgery, it goes to zero, but maybe one or two years later,
the PSA is going up again. How could that be? It means that there was prostate cancer cells
somewhere outside of surgery or radiation that we couldn't get at the beginning. That's called
a PSA relapse or a biochemical relapse. And if that's the case, I can help patients predict
what are the odds that that could happen. So that's all based on the risk group. And the risk
grouping is pretty straightforward. Low risk means your PSA is less than 10. Your Gleason score is
six or less by an expert. And that when we examine your prostate or look with MRI, it looks pretty
normal. High risk, your PSA is more than 20. Your Gleason score is an eight, nine or 10 by an expert
or the tumor in the prostate is very big, what we call T3. Now, intermediates are not low and
they're not high. So it's a pretty clear system, but here's a caveat. To be a low risk in the low
risk group, you need to have all of the low risk features. If you have a single high risk feature,
a PSA of 22 and everything else great, you're still high risk. So one high risk feature and
you're in the high risk group, all low risk features to be in the low risk group. Why does
this matter? Low risk patients who go for surgery or radiation are overwhelmingly likely to be cured
10 years later. The chance of a PSA relapse is probably 10% or less. The flip side, if you're
in a high risk group, the chance of PSA relapse in the first five years exceeds 50%. And if you
have count the number of biopsies that have cancer in it. So you might get 10 biopsies. If
seven have cancer in it, that also puts you in a high risk group and having more prostate biopsies
with cancer, even in the intermediate group, the chance of PSA relapse probably is a hundred percent
at five years. So putting patients into these risk groups is really critical to help decide
how they want to treat or manage prostate cancer. For example, if you are a very low risk patient,
I might say something to those patients like, you're an excellent candidate for surgery or
radiation in any form, but I might not recommend them because there's no survival advantage.
You won't live longer. You'll live longer without a prostate, but you don't get a survival advantage
in that case, but you get all the risks of doing surgery or radiation. Those patients, I think that
observation or active surveillance is a good choice. The flip side, a high risk patient,
I might say John Doe is a high risk, newly diagnosed prostate cancer patient who could
do surgery or radiation, but I don't recommend it because of the very high chance that his PSA
will start going up right after surgery and he might be an excellent candidate for, say,
hormones plus radiation, a combined treatment, and he wouldn't be a good candidate for observation.
The intermediate cases are definitely more challenging, but we have to put all of this
information in context of other disease. So a second opinion from, say, a cardiologist
or a good family medicine doctor who knows you becomes critical because if you have diabetes,
obesity, heart disease, a stent, a bypass, on dialysis, or some other chronic disease,
or take medicine like chronic blood thinners, then radiation and surgery might not be good
choices. It's really important that you don't rush into any decision making because the facts
of the matter are we have multiple randomized clinical trials in prostate medicine that still
don't show that surgery or radiation compared to observation or watchful waiting have a survival
advantage for our patients. We know that the patients who take surgery or radiation are going
to have more side effects, but the men on the observation arm don't have to suffer that risk.
Now, they do have progressive prostate growth, prostate cancer growth, but they can do surgery
or radiation later. The bottom line is if you have chronic medical conditions,
maybe those are more important than an early low-risk prostate cancer. And when one of the
legitimate options is observation, there's no rush to judgment. I get it. I'm a medical oncologist
and talk to cancer patients every day. Cancer is the single most frightening word in any language.
Cancer is an emotional emergency. It's not something that you have to run to A&E and say,
I need treatment right away. So take a deep breath, think about how you want to be treated
and what's going to be best for you in the long run, and then you can start to make some
logical decisions that'll be right for you. I'm Dr. Stephen Tucker. Thanks for listening.
If you have any questions or comments, leave them in the box below.
